Estimation of glomerular filtration rate to prevent life-threatening hyperkalemia due to combined therapy with spironolactone and angiotensin-converting enzyme inhibition or angiotensin receptor blockade
- 1 September 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (6) , 662-663
- https://doi.org/10.1016/s0002-9149(02)02580-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactoneThe American Journal of Medicine, 2001
- Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 casesThe American Journal of Medicine, 2001
- Predictors of the Development of Hyperkalemia in Patients Using Angiotensin-Converting Enzyme InhibitorsAmerican Journal of Nephrology, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Changes in Renal Function with AgingClinics in Geriatric Medicine, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997